Senti Biosciences, Inc. (SNTI) financial statements and ratios from SEC XBRL: revenue $22000.00 (TTM), net margin -279263.6%, revenue growth -100.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $22000.00 |
| Net Margin | -279263.6% |
| Return on Equity | 1457.3% |
| Current Ratio | 0.83 |
| Revenue Growth (YoY) | -100.0% |
| Revenue Growth (3Y) | -100.0% |
| EPS Growth (YoY) | 651.9% |
| FCF Growth (YoY) | -35.7% |
| Price / Sales | 241.53 |
| FCF Yield | -494.3% |
| Altman Z-Score | -13.86 (distress) |
| Sector P/E (Healthcare) | 21.7 |
SNTI overview · SNTI earnings · SNTI KPIs · SNTI investor relations · SNTI ownership · SNTI peers · SNTI filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.